San Diego-based Adamis Pharmaceuticals Corporation, a biopharmaceutical company that specializes in the development and commercialization of products for various therapeutic areas, has added new items to its portfolio. The company's products are aimed at treating allergy, opioid overdose, respiratory, and inflammatory diseases. Among them are SYMJEPI epinephrine injectable pre-filled single-dose syringe products that can be used in emergency situations to treat acute allergic reactions, including anaphylaxis. Adamis also offers the ZIMHI naloxone injection to battle opioid overdose. The company was established in 2006 with its headquarters in San Diego, California.